Eptifibatide

Eptifibatide

SCHEMBL29353236

NC(=O)[C@@H]1CSSCCC(=O)N[C@@H](CCCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@H]2C(=O)N1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ITGA2BITGB3

The experimentally established mechanism targets of Eptifibatide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB3 known ✓ P05106 5/20 1.00
ITGA2B known ✓ P08514 3/20 1.00
ITGAV P06756 5/20 1.00
MC3R P41968 5/20 0.59
MC5R P33032 4/20 0.59
MC4R P32245 3/20 0.59
ITGA5 P08648 4/20 0.57
ITGB1 P05556 2/20 0.57
ITGB5 P18084 2/20 0.57
LDLR P01130 9/20 0.57
PCSK9 Q8NBP7 9/20 0.57
KLK5 Q9Y337 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eptifibatide SCHEMBL18504808 1.00 ITGB3 (1.00) ITGB3ITGAVITGA2BMC3RMC5R
Eptifibatide SCHEMBL43237 1.00 ITGB3 (1.00) ITGB3ITGAVITGA2BMC3RMC5R
Eptifibatide SCHEMBL22193879 1.00 ITGB3 (1.00) ITGB3ITGAVITGA2BMC3RMC5R
Eptifibatide SCHEMBL16883987 1.00 ITGB3 (1.00) ITGB3ITGAVITGA2BMC3RMC5R
Eptifibatide SCHEMBL1649793 1.00 ITGB3 (1.00) ITGB3ITGAVITGA2BMC3RMC5R
Eptifibatide SCHEMBL16884017 1.00 ITGB3 (1.00) ITGB3ITGAVITGA2BMC3RMC5R
SCHEMBL29356871 0.98 ITGB3 (0.97) ITGB3ITGAVITGA2BMC3RMC5R
SCHEMBL16883997 0.93 ITGB3 (0.87) ITGB3ITGAVITGA2BLDLRPCSK9
SCHEMBL24433345 0.93 ITGB3 (0.86) ITGB3ITGAVITGA2BMC3RMC5R
SCHEMBL16883930 0.91 ITGB3 (0.84) ITGB3ITGAVITGA2BMC3RMC5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 943 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122095549-A Bulk acoustic wave element and method for manufacturing the same 2026-05-26 CN claimed
CN-121558691-B Drainage pipeline sewage leakage diagnosis method based on clean water introduction TONGJI UNIVERSITY (CN) 2026-05-26 CN claimed
US-20260119915-A1 SENTIX-IED - Decision State Intelligence System JUNIOR JOSE REGINALDO VALENTE (BR) 2026-04-30 US claimed
US-12473572-B1 Gallid alphaherpesvirus 3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry FARMACOLÓGICOS VETERINARIOS S.A.C. (PE) 2025-11-18 US claimed
US-12441989-B2 Serum-free medium for avian vaccine production and uses thereof BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2025-10-14 US claimed
CN-120070742-A Instance segmentation and model reconstruction method and system based on deep learning and synthetic point cloud 东南大学 2025-05-30 CN claimed
CN-119955984-A RNA virus detection probe, on-paper sensor, and preparation method and application of on-paper sensor 湖南大学 2025-05-09 CN claimed
CN-119968634-A Method and apparatus for processing data associated with a hardware security module 罗伯特·博世有限公司 2025-05-09 CN claimed
CN-119912569-A Anti-SIRP-beta 1 antibodies and methods of use thereof 艾利妥 2025-05-02 CN claimed
CN-114993351-B Magnetometer real-time calibration method and computer system based on variable forgetting factor 天璺科技(上海)有限公司 2025-05-02 CN claimed
WO-2022077536-A1 INDUSTRIAL DESIGN SYSTEM FOR IMPROVING INTERACTIVE EXPERIENCE AND INTERACTION METHOD THEREOF 垒途智能教科技术研究院江苏有限公司 2022-04-21 WO claimed
CN-111402561-B Marketing system and method 江苏经贸职业技术学院 2022-04-15 CN claimed
CN-114317827-A Multiplex PCR (polymerase chain reaction) primer, method and application for identifying infection and immunity of Marek's disease viruses of different serotypes 河南省农业科学院 2022-04-12 CN claimed
CN-114325238-A Low-voltage distribution line fault positioning method and system 上海尤比酷电气有限公司 2022-04-12 CN claimed
US-20220105174-A1 RECOMBINANT GALLID HERPESVIRUS 3 VACCINES ENCODING HETEROLOGOUS AVIAN PATHOGEN ANTIGENS THE PIRBRIGHT INSTITUTE (GB) 2022-04-07 US claimed
CN-114267131-A Ultrahigh express delivery cabinet pickup method and system 上海蜜罐信息科技有限公司 2022-04-01 CN claimed
CN-216077675-U Electric fan capable of being automatically disconnected in power failure 山西大学 2022-03-18 CN claimed
CN-114202863-A Multi-user simultaneous pickup method and system for ultrahigh express cabinet 上海蜜罐科技有限公司 2022-03-18 CN claimed
CN-111040724-B Adhesive for crosslinked polyethylene and silicone rubber, preparation method and use method 杭州矽能新材料有限公司 2022-03-08 CN claimed
EP-3391903-B1 RECOMBINANT GALLID HERPESVIRUS 3 VACCINES ENCODING HETEROLOGOUS AVIAN PATHOGEN ANTIGENS THE PIRBRIGHT INST (GB) 2022-02-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260119915-A1 SENTIX-IED - Decision State Intelligence System IKBKG, TSNAX, FHIT ITGB3 3244/4885ITGA2B 1714/4885ITGAV 1912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.